Alemtuzumab CARE-MS I 5-year follow-up Durable efficacy in the absence of continuous MS therapy
Volume
89
Pagination
1107 - 1116
DOI
10.1212/WNL.0000000000004313
Journal
NEUROLOGY
Issue
ISSN
0028-3878
Metadata
Show full item recordAuthors
Havrdova, E; Arnold, DL; Cohen, JA; Hartung, H-P; Fox, EJ; Giovannoni, G; Schippling, S; Selmaj, KW; Traboulsee, A; Compston, DASURI
http://www.neurology.org/cgi/pmidlookup?view=long&pmid=28835401http://qmro.qmul.ac.uk/xmlui/handle/123456789/34804